Life years lost-comparing potentially fatal late complications after radiotherapy for pediatric medulloblastoma on a common scale

Cancer

Volumn 118, Issue 21, 2012, Pages 5432-5440

  Brodin, N Patrik ^a,b   Vogelius, Ivan R ^a   Maraldo, Maja V ^a   Munck Af Rosenschöld, Per ^a,b   Aznar, Marianne C ^a,b   Kiil Berthelsen, Anne ^a   Nilsson, Per ^c   Björk Eriksson, Thomas ^c   Specht, Lena ^a,d   Bentzen, Sãren M ^a,e  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

late effects; life years lost; radiotherapy; risk modeling; secondary cancers

Indexed keywords

ADOLESCENT; AGE; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CHILD; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; HAZARD RATIO; HEART FAILURE; HEART INFARCTION; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LIFESPAN; LUNG CANCER; MALE; MEDULLOBLASTOMA; MORTALITY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION DOSE; RISK ASSESSMENT; SCHOOL CHILD; SEX; STOMACH CANCER; THREE DIMENSIONAL CONFORMAL RADIOTHERAPY; THYROID CANCER; VOLUMETRIC MODULATED ARC THERAPY;

ADOLESCENT; AGE FACTORS; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; CRANIOSPINAL IRRADIATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; MALE; MEDULLOBLASTOMA; PROTONS; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; RISK;

EID: 84867863152     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27536     Document Type: Article

References (25)

1. Armstrong GT,. Long-term survivors of childhood central nervous system malignancies: the experience of the Childhood Cancer Survivor Study. Eur J Paediatr Neurol. 2010; 14: 298-303.
2. Darby SC, McGale P, Taylor CW, et al. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol. 2005; 6: 557-565.
3. Meadows AT, Friedman DL, Neglia JP, et al. Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. J Clin Oncol. 2009; 27: 2356-2362.
4. Brodin NP, Rosenschold PM, Aznar MC, et al. Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma. Acta Oncol. 2011; 50: 806-816.
5. Schneider U, Zwahlen D, Ross D, et al. Estimation of radiation-induced cancer from 3-dimensional dose distributions: concept of organ equivalent dose. Int J Radiat Oncol Biol Phys. 2005; 61: 1510-1515.
6. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2008, National Cancer Institute. On the basis of the November 2010 SEER data submission, posted to the SEER web site 2011. Bethesda, MD: National Cancer Institute; 2011. Available at: http://seer.cancer.gov/csr/1975-2008. Accessed June 14, 2001.
7. Mertens AC, Liu Q, Neglia JP, et al. Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2008; 100: 1368-1379.
8. Travis LB, Hill DA, Dores GM, et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA. 2003; 290: 465-475.
9. Kenney LB, Yasui Y, Inskip PD, et al. Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Intern Med. 2004; 141: 590-597.
10. Travis LB, Gilbert E,. Lung cancer after Hodgkin lymphoma: the roles of chemotherapy, radiotherapy and tobacco use. Radiat Res 2005; 163: 695-696.
11. Swerdlow AJ, Barber AJ, Hudson GV, et al. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol. 2000; 18: 498-509.
12. Bassal M, Mertens AC, Taylor L, et al. Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2006; 24: 476-483.
13. Bhatti P, Veiga LH, Ronckers CM, et al. Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study. Radiat Res. 2010; 174: 741-752.
14. van den Belt-Dousebout AW, Aleman BM, Besseling G, et al. Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy. Int J Radiat Oncol Biol Phys. 2009; 75: 1420-1429.
15. Mulrooney DA, Yeazel MW, Kawashima T, et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort [serial online]. BMJ. 2009; 339: b4606.
16. Centers for Disease Control and Prevention. National Center for Health Statistics. Health Data Interactive. Available at: www.cdc.gov/nchs/hdi.htm. Accessed January 11, 2011.
17. 4: a randomized multicentre study of hyperfractionated versus conventional radiotherapy in children with standard risk medulloblastoma [abstract]. Pediatr Blood Cancer. 2008; 50 (suppl): 45-46.
18. Newhauser WD, Fontenot JD, Mahajan A, et al. The risk of developing a second cancer after receiving craniospinal proton irradiation. Phys Med Biol. 2009; 54: 2277-2291.
19. International Commission on Radiological Protection (ICRP). Relative biological effectiveness (RBE), quality factor (Q), and radiation weighting factor (w). Report no. 92. Oxford, United Kingdom: International Commission on Radiological Protection; 2003.
20. Travis LB, Hill D, Dores GM, et al. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J Natl Cancer Inst. 2005; 97: 1428-1437.
21. Yeh JM, Nekhlyudov L, Goldie SJ, et al. A model-based estimate of cumulative excess mortality in survivors of childhood cancer. Ann Intern Med. 2010; 152: 409-408.
22. Mu X, Bjork-Eriksson T, Nill S, et al. Does electron and proton therapy reduce the risk of radiation induced cancer after spinal irradiation for childhood medulloblastoma? A comparative treatment planning study. Acta Oncol. 2005; 44: 554-562.
23. Miralbell R, Lomax A, Cella L, et al. Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int J Radiat Oncol Biol Phys. 2002; 54: 824-829.
24. Geenen MM, Bakker PJ, Kremer LC, et al. Increased prevalence of risk factors for cardiovascular disease in long-term survivors of acute lymphoblastic leukemia and Wilms tumor treated with radiotherapy. Pediatr Blood Cancer. 2010; 55: 690-697.
25. Lundkvist J, Ekman M, Ericsson SR, et al. Cost-effectiveness of proton radiation in the treatment of childhood medulloblastoma. Cancer. 2005; 103: 793-801.